Event Brief
Common antidepressant may aid long COVID recovery
Filed: Apr 02, 2026 at 3:07 PM ET
Summary: A study shows fluvoxamine significantly improves fatigue and quality of life in adults with long COVID.
WHO: Edward Mills
WHAT: Study on fluvoxamine's effects on long COVID
WHEN: Apr 02, 2026 at 2:38 PM ET
WHERE: Canada
WHY: To provide evidence-based treatment options for long COVID patients.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →